12/24
09:35 am
tndm
Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica [Yahoo! Finance]
Low
Report
Insulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica [Yahoo! Finance]
12/11
02:44 pm
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Citigroup Inc. from $57.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Citigroup Inc. from $57.00 to $50.00. They now have a "buy" rating on the stock.
12/10
09:00 am
tndm
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
Medium
Report
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
12/2
07:08 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $45.00 price target on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $45.00 price target on the stock.
11/27
11:11 pm
tndm
Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own [Seeking Alpha]
Medium
Report
Tandem Diabetes: Recurring Value Erosion, Not Right Point In Cycle To Own [Seeking Alpha]
11/21
04:11 pm
tndm
Tandem Diabetes Care Announces Upcoming Conference Presentations [Yahoo! Finance]
Low
Report
Tandem Diabetes Care Announces Upcoming Conference Presentations [Yahoo! Finance]
11/21
04:05 pm
tndm
Tandem Diabetes Care Announces Upcoming Conference Presentations
Low
Report
Tandem Diabetes Care Announces Upcoming Conference Presentations
11/8
01:44 pm
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Barclays PLC from $58.00 to $60.00. They now have an "overweight" rating on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Barclays PLC from $58.00 to $60.00. They now have an "overweight" rating on the stock.
11/8
09:58 am
tndm
TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket [Yahoo! Finance]
Medium
Report
TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket [Yahoo! Finance]
11/8
05:39 am
tndm
Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report [Yahoo! Finance]
Medium
Report
Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report [Yahoo! Finance]
11/7
02:34 pm
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $57.00 to $56.00. They now have a "buy" rating on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $57.00 to $56.00. They now have a "buy" rating on the stock.
11/7
01:41 pm
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Robert W. Baird from $39.00 to $37.00. They now have a "neutral" rating on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target lowered by analysts at Robert W. Baird from $39.00 to $37.00. They now have a "neutral" rating on the stock.
11/7
02:31 am
tndm
Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
Low
Report
Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
11/6
08:28 pm
tndm
Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
11/6
04:05 pm
tndm
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
Medium
Report
Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
11/6
07:32 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $42.00 price target on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $42.00 price target on the stock.
10/30
04:05 pm
tndm
Tandem Diabetes Care Announces Upcoming Conference Participation
Medium
Report
Tandem Diabetes Care Announces Upcoming Conference Participation
10/24
08:42 am
tndm
Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 14% this week, taking three-year losses to 75% [Yahoo! Finance]
Low
Report
Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 14% this week, taking three-year losses to 75% [Yahoo! Finance]
10/15
09:22 am
tndm
France Diabetes Devices Market Report (2024-2032) with Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom [Yahoo! Finance]
Low
Report
France Diabetes Devices Market Report (2024-2032) with Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom [Yahoo! Finance]
10/4
10:46 am
tndm
Medtronic issues recall for MiniMed insulin pumps over battery issues [Seeking Alpha]
Medium
Report
Medtronic issues recall for MiniMed insulin pumps over battery issues [Seeking Alpha]
10/4
08:06 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $46.00 price target on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $46.00 price target on the stock.
10/2
04:05 pm
tndm
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
Low
Report
Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024
10/2
08:08 am
tndm
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $65.00 price target on the stock.
Low
Report
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $65.00 price target on the stock.
10/1
05:46 pm
tndm
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday [Yahoo! Finance]
Low
Report
Why Tandem Diabetes Care Stock Took It on the Chin Tuesday [Yahoo! Finance]
10/1
02:35 pm
tndm
t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock [Yahoo! Finance]
Low
Report
t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock [Yahoo! Finance]